# OnCo record paper-xia-h101-head-neck-aizheng-2004 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-xia-h101-head-neck-aizheng-2004/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-xia-h101-head-neck-aizheng-2004" ;
  schema:name "Xia 2004: the randomised trial behind China's approval of the oncolytic adenovirus H101"@en ;
  schema:description "Adding injections of an engineered adenovirus to chemotherapy roughly doubled the proportion of head and neck or oesophageal cancers that shrank, but the trial reported no survival figures."@en ;
  schema:url <https://onco.cc/key-papers/paper-xia-h101-head-neck-aizheng-2004/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/15601557/>, <https://europepmc.org/article/MED/15601557> ;
  schema:datePublished "2004"^^xsd:gYear ;
  schema:author "Xia ZJ, Chang JH, Zhang L, et al." ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/oncolytic-virus/> .